Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbetocin Versus Misoprostol for the Prevention of Postpartum Hemorrhage After Vaginal Delivery in Women With Risk Factors: A Prospective Randomized Study

NCT07353281 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT07353281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07353281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbetocin Versus Misoprostol for the Prevention of Postpartum Hemorrhage After Vaginal Delivery in Women With Risk Factors: A Prospective Randomized Study
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
January 1, 2028
Enrollment
146 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum complication, postpartum hemorrhage